United States: Hello Budget Agreement; Goodbye Provider-Based Status?

H.R. 1314, the Bipartisan Budget Act of 2015, was signed into law by President Obama on November 2, 2015. The two-year budget framework, which raises the federal debt limit through March 2017, partially rolls back the Budget Control Act's discretionary caps by $80 billion above the sequester level for two consecutive years (FY 2016 and 2017). The government is currently operating under a continuing resolution that expires December 11, 2015, which leaves congressional appropriators little more than a month to pull together an omnibus spending package for FY 2016. Provisions in the Act of interest to the healthcare industry include a policy change that promises to significantly influence the future of provider-based reimbursement.

Hospital Off-Campus Departments

Section 603 of the Act removes a reimbursement incentive for hospitals to acquire certain physician practices, ambulatory surgery centers, and other providers for purposes of creating outpatient alternatives. Services provided by hospitals in off-campus departments created on or after November 2, 2015, will be limited to non-hospital reimbursement (e.g., physician fee schedule) beginning January 1, 2017, except for services furnished in a dedicated off-campus emergency department. Off-campus departments are generally facilities that are not located within the physical area immediately adjacent to the provider's main buildings, including areas and structures that are not strictly contiguous to the main buildings but are located within 250 yards of the main buildings.

This effort to neutralize site-of-service disparities may also impact the eligibility of off-campus patients to receive drugs pursuant to the 340B program. Under the 340B program, discounts are extended only to a hospital's outpatient locations that are reported as Medicare-reimbursable outpatient locations on the hospital's cost report. If the reimbursement change removes new off-campus departments from the hospital's cost report, or if the Health Resources and Services Administration determines that the locations are no longer part of the hospital as a result of the reimbursement change, outpatient drugs prescribed or dispensed at such locations could be ineligible for 340B discounts.

Elections Coming Up - Have I Got an Actuarially Fair Part B Deal for You

Section 601 of the Act is somewhat complicated to explain, as you have to follow the money under the congressional shells moving around quickly.

Twenty-five percent of Medicare Part B premiums must be covered by beneficiaries. However, when an increase in costs occurs, the percentage increase to approximately 70 percent of the Part B beneficiaries is limited to the percentage increase in their Social Security checks (Hold Harmless Beneficiaries). Unfortunately, for 2016 there will be no Social Security increase. So, the remaining 30 percent of the Medicare beneficiaries (Contributors) will have to pay the projected increased Part B costs for the Hold Harmless Beneficiaries.

Naturally, a 52 percent premium increase ($54 per month), the monthly Part B premium increase projected for the Contributors in 2016, would be a bad idea in an election year. So to cover the cost of the increase for the Hold Harmless Beneficiaries (Shortfall), the Contributors will pay an additional $15, or 15 percent more, per month (which is the amount that would have been payable if the cost increase were paid by all part B enrollees), and the U.S. Treasury will loan the Supplemental Medical Insurance Trust Fund funds to cover the Shortfall. Section 601 then provides that the Contributors will pay an additional $3 in their monthly Part B premium beginning in 2016 until the loan is repaid. However, those paying income-related premium adjustments will pay more than $3 per month. Assuming no interest, it will take only approximately 13 years to repay the loan. Current beneficiaries will likely no longer remember the loan when the last payment is made, so everyone wins.

The same provision to protect Contributors will apply for 2017, as no one wants a surprise just before a presidential election.

Large Employer Health Insurance Auto-Enrollment Repealed (But Not Replaced)

Section 604 of the Act repealed the Affordable Care Act's (ACA) requirement for employers with more than 200 employees that offer health insurance to automatically enroll new employees in a health plan. This provision was designed to enroll employees in health plans when inertia and ambivalence might otherwise have led them to ignore opportunities to enroll in an employer's health insurance program. It is estimated that the repeal of ACA Section 1511 will reduce employer-covered insureds by approximately 750,000 beginning in 2017 and that 90 percent of these individuals will not obtain other coverage.

There was little enthusiasm within the administration for the auto-enrollment provision. The U.S. Departments of Labor and Justice were to have drafted regulations to implement Section 1511 but failed to do so. Consensus within Washington was that it was only a matter of time before the section was repealed and not replaced.

Civil Monetary Penalty Inflation Adjustments

Despite that civil monetary penalties (CMPs) are already considered excessive by many, Congress has quietly imposed substantial increases. Section 701 of the Act requires the Centers for Medicare and Medicaid Services (CMS) and other federal agencies to increase CMPs, including False Claims Act (FCA) penalties, for inflation. The initial "catch up adjustment" increases the CMPs by a cost-of-living adjustment determined based on the percentage change in the Consumer Price Index (CPI) between October 2015 and the CPI level in October of the year in which the penalty amount was established or last adjusted. Thereafter, the amount will increase by the annual CPI change.

The FCA penalties were last set in 1999 to their present level of between $5,500 and $11,000. In October 1999, the CPI level was 168.3. The last reported CPI for September 2015 was 237.945. This results in a 41.4 percent increase. Thus, after adjustments for inflation, FCA penalties will be $7,775.98 and $15,551.96. The initial increase will be imposed not later than August 1, 2016, and annual adjustments will be made by January 15 of every year thereafter. The "improved" CMPs will be applicable to all violations, including violations that predated the increase in the amount of the penalty.

The Act, however, provides that an agency may adjust the amount of a CMP by less than the otherwise required amount if it determines that (1) increasing the CMP will have a negative economic impact, or (2) the social costs of increasing the CMP by the otherwise required amount outweigh the benefits, and the director of the Office of Management and Budget concurs with the determination of the agency. Given the process, it is unlikely that agencies will seek to limit the increased penalties.

Medicaid Drug Inflationary Rebate

Section 602 of the Act applies an additional inflationary Medicare rebate requirement to generic drugs. Specifically, non-innovator multiple source drugs (Generic Drugs) require a base rebate per unit amount of 13 percent of the Average Manufacturer Price (AMP). Single source drugs and innovator multiple source drugs (Brand Name Drugs) require a base rebate per unit amount of 23.1 percent of the AMP or the difference between the AMP and the Best Price of the drug. Section 602 of the Act applies the inflation-based rebate currently paid on Brand Name Drugs to Generic Drugs. Thus, Generic Drug manufacturers will likely have to pay higher Medicaid rebates on their products if they increase prices faster than the calculated rate of inflation.

New and More Pungent Penalties

Section 813 of the Act provides that a person who receives a fee or other income for services performed in connection with any Social Security benefit determination (including a claimant representative, translator, or current or former employee of the Social Security Administration) or who is a physician or other healthcare provider who submits, or causes the submission of, false medical or other evidence in connection with any such determination, will be subject to increased penalties.

Advertising Penalties

If a provider uses the Internet or e-mail in a manner that they know or should know would convey, or reasonably could be interpreted or construed as conveying, the false impression that their item or service is approved, endorsed, or authorized by the Social Security Administration, CMS, or the U.S. Department of Health and Human Services (HHS) or that such person has some connection with, or authorization from, the Social Security Administration, CMS, or HHS, the penalty has been increased by Section 814 of the Act by making each dissemination, viewing, or accessing of such a communication a separate violation.

In the Year 2025

Finally, Section 101 extended the annual 2 percent reduction of Medicare provider reimbursement for an additional year, into 2025. The provider reimbursement reduction was originally set to expire in 2021; however, Congress has used extensions of the reimbursement limitation as a free pay-for on other measures.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.